Literature DB >> 22863553

Current research status of endoscopic submucosal dissection for colorectal neoplasms.

Chen Huang1, Ren-Xiang Huang, Ping Xiang, Zheng-Jun Qiu.   

Abstract

Endoscopic submucosal dissection (ESD) has been applied to, and gradually standardized for, early gastric cancers; however, it has not yet been widely used for treatment of colorectal neoplasms. Compared with gastric ESD, the thinner colorectal wall and winding nature of the colon make colorectal ESD a much more difficult operative technique. Despite greater risks of postoperative complications, particularly perforation of the colon, more and more endoscopists are making an effort to study this new technique in terms of its capability of larger neoplastic resection, higher en bloc resection rate and lower local recurrence rate of neoplasms in comparison with other endoscopic treatments. Thus, colorectal ESD may become the standard treatment for early colorectal neoplasms in the future. This review article discusses the current research on endoscopic submucosal dissection for colorectal neoplasms. Please see supplementary files for the accompanying video ESD with snare.

Entities:  

Mesh:

Year:  2012        PMID: 22863553     DOI: 10.25011/cim.v35i4.17147

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  7 in total

Review 1.  Complications during colonoscopy: prevention, diagnosis, and management.

Authors:  R Manta; F Tremolaterra; A Arezzo; M Verra; G Galloro; L Dioscoridi; F Pugliese; A Zullo; M Mutignani; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-07-11       Impact factor: 3.781

Review 2.  Endoscopic submucosal dissection versus local excision for early rectal cancer: a systematic review and meta-analysis.

Authors:  S Wang; S Gao; W Yang; S Guo; Y Li
Journal:  Tech Coloproctol       Date:  2015-10-30       Impact factor: 3.781

3.  Learning colorectal endoscopic submucosal dissection: a prospective learning curve study using a novel ex vivo simulator.

Authors:  Mark A Gromski; Jonah Cohen; Kayoko Saito; Jean-Michel Gonzalez; Mandeep Sawhney; Changdon Kang; Andrew Moore; Kai Matthes
Journal:  Surg Endosc       Date:  2017-03-09       Impact factor: 4.584

4.  TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells.

Authors:  Qinmin Li; Ruihua Shi; Yundong Wang; Xiaoping Niu
Journal:  Tumour Biol       Date:  2012-11-09

Review 5.  A novel opportunity in minimally invasive colorectal cancer therapy: defining a role for endoscopic submucosal dissection in the United States.

Authors:  Jonah Cohen
Journal:  Diagn Ther Endosc       Date:  2013-11-06

6.  Predictors of lymph-node metastasis in surgically resected T1 colorectal cancer in Western populations.

Authors:  Zhen Zong; Hui Li; Ce-Gui Hu; Fu-Xin Tang; Zhi-Yang Liu; Peng Deng; Tai-Cheng Zhou; Cheng-Hao Yi
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-01-26

Review 7.  Snare tip soft coagulation (STSC) after endoscopic mucosal resection (EMR) of large (> 20 mm) non pedunculated colorectal polyps: a systematic review and meta-analysis.

Authors:  Saurabh Chandan; Antonio Facciorusso; Daryl Ramai; Smit Deliwala; Babu P Mohan; Lena L Kassab; Peter V Draganov; Mohamed O Othman; Gursimran S Kochhar
Journal:  Endosc Int Open       Date:  2022-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.